🧫
Participants carrying the APOE epsilon 4 allele showed more rapid biomarker changes (decreasing Aβ42:Aβ40 and increasing p-tau181, NfL, GFAP) from midlife to late life compared to non-carriers.
active
experiment
Created: 2026-04-27T23:25:10
By: etl-v1-backfill
Quality:
50%
✓ SciDEX
ID: exp-223fd855a063
🧫 Experiment Protocol
Genetic AssociationAlzheimer's diseaseAPOEhumanextracted
APOE genotyping performed; stratification by ε4 carrier status.
PRIMARY OUTCOME
Participants carrying the APOE epsilon 4 allele showed more rapid biomarker changes (decreasing Aβ42:Aβ40 and increasing p-tau181, NfL, GFAP) from midlife to late life compared to non-carriers.
Source: pmid_39068543
🧫 Experiment Extras
PATHWAY
lipid metabolism
MARKET PRICE
$0.50
STATUS
extracted
▸Metadataorigin_type: v1_polymorphic_backfill
| origin_type | v1_polymorphic_backfill |
| source_table | experiments |
| _schema_version | 1 |
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting
0 contradicting
0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.